tiprankstipranks
SI-Bone Inc (SIBN)
NASDAQ:SIBN
US Market

SI-Bone (SIBN) Earnings Dates, Call Summary & Reports

Compare
172 Followers

Earnings Data

Report Date
May 12, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.23
Last Year’s EPS
-0.27
Same Quarter Last Year
Based on 8 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 24, 2025
|
% Change Since: -2.98%
|
Next Earnings Date:May 12, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, successful product launches, and positive adjusted EBITDA, indicating robust business momentum. However, challenges such as the ongoing DOJ investigation and assumptions of ASP decline provide some areas of concern.
Company Guidance
In the fourth quarter of 2024, SI-BONE achieved a record $49 million in worldwide revenue, marking a growth of over 26%. U.S. revenue rose by an impressive 28% to $46.9 million, driven by strong demand from nearly 1,400 active physicians. SI-BONE's strategic focus on innovation and physician engagement resulted in positive adjusted EBITDA for the quarter and is expected to continue for the full year 2025, with margins anticipated to expand. The company plans to selectively increase its direct sales force and leverage a hybrid model with third-party agents to capitalize on the strong procedural demand. SI-BONE has set key growth priorities for 2025, including targeted commercial initiatives, enhancing procedure density, and preparing for the launch of new disruptive products. The company's initiatives have also resulted in a 23% growth in active physicians and a 70% revenue increase from physicians previously trained as residents and fellows. Looking ahead, SI-BONE expects to generate worldwide revenue of $193.5 to $195.5 million in 2025, implying a year-over-year growth of approximately 16% to 17%, with the goal of achieving positive free cash flow.
Record-Breaking Revenue and Growth
SI-BONE delivered a record $49 million in worldwide revenue for Q4 2024, representing growth exceeding 26%. U.S. revenue increased by 28% to $46.9 million driven by strong demand from nearly 1,400 active physicians.
Product Launch Success
Granite 9.5 and TNT launches exceeded expectations, with Granite 9.5 gaining strong momentum and TNT seeing rapid adoption. Both products are expected to be major growth drivers in 2025.
Positive Adjusted EBITDA
SI-BONE achieved positive adjusted EBITDA of $1.9 million in Q4 2024, a significant improvement from the previous year's adjusted EBITDA loss of $4.8 million.
Strong Physician Engagement
Record number of physicians trained in 2024, with nearly 2,000 U.S. physicians performing at least one procedure. Active physicians grew by 23%, with a 40% increase in physicians performing multiple procedure types.
Breakthrough Device Designations
Received breakthrough device designation from the FDA for a new novel implant system, marking SI-BONE's third BDD product, positioning the company as a leader in innovation.
---

SI-Bone (SIBN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SIBN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 12, 20252025 (Q1)
-0.23 / -
-0.27
Feb 24, 20252024 (Q4)
-0.14 / -0.11
-0.2759.26% (+0.16)
Nov 12, 20242024 (Q3)
-0.24 / -0.16
-0.2536.00% (+0.09)
Aug 05, 20242024 (Q2)
-0.28 / -0.22
-0.326.67% (+0.08)
May 06, 20242024 (Q1)
-0.31 / -0.27
-0.3215.62% (+0.05)
Feb 26, 20242023 (Q4)
-0.28 / -0.27
-0.3215.62% (+0.05)
Nov 06, 20232023 (Q3)
-0.34 / -0.25
-0.4139.02% (+0.16)
Aug 07, 20232023 (Q2)
-0.40 / -0.30
-0.5444.44% (+0.24)
May 01, 20232023 (Q1)
-0.41 / -0.32
-0.5238.46% (+0.20)
Feb 27, 20232022 (Q4)
-0.40 / -0.32
-0.4325.58% (+0.11)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

SIBN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 24, 2025$17.47$18.44+5.55%
Nov 12, 2024$15.63$13.14-15.93%
Aug 05, 2024$14.04$14.22+1.28%
May 06, 2024$14.48$15.68+8.29%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does SI-Bone Inc (SIBN) report earnings?
SI-Bone Inc (SIBN) is schdueled to report earning on May 12, 2025, TBA Not Confirmed.
    What is SI-Bone Inc (SIBN) earnings time?
    SI-Bone Inc (SIBN) earnings time is at May 12, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SIBN EPS forecast?
          SIBN EPS forecast for the fiscal quarter 2025 (Q1) is -0.23.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis